Patent · US Active

Mixed inhibitors of aminopeptidase N and neprilysin

US9388129B2 · kind B2 · utility

1Cited by

9References

22Claims

0Family size

Assignee

PHARMALEADS · FR

Inventors

Bernard Roques · Paris, FR
Marie-Claude Fournie-Zaluski · Paris, FR
Hervé Poras · Bailly, FR

Key dates

Filing date	Oct 23, 2013
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Oct 23, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Mixed inhibitors of aminopeptidase N and neprilysin are disclosed. Pharmaceutical compositions containing at least one of these compounds, used alone or in combination with morphine and derivatives thereof, endocannabinoids and inhibitors of endocannabinoid metabolism, GABA derivatives such as gabapentin or pregabalin, duloxetine or methadone, can be used as an analgesic, anxiolytic, antidepressant or anti-inflammatory.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.